Abstract
Glioma-initiating cells (GICs) represent a potential important therapeutic target because they are likely to account for the frequent recurrence of malignant gliomas; however, their identity remains unsolved. Here, we characterized the cellular lineage fingerprint of GICs through a combination of electrophysiology, lineage marker expression, and differentiation assays of 5 human patient-derived primary GIC lines. Most GICs coexpressed nestin, NG2 proteoglycan, platelet-derived growth factor receptor-α, and glial fibrillary acidic protein. Glioma-initiating cells could be partially differentiated into astrocytic but not oligodendroglial or neural lineages. We also demonstrate that GICs have a characteristic electrophysiologic profile distinct from that of well-characterized tumor bulk cells. Together, our results suggest that GICs represent a unique type of cells reminiscent of an immature phenotype that closely resembles but is not identical to NG2 glia with respect to marker expression and functional membrane properties. Copyright © 2013 by the American Association of Neuropathologists, Inc.
Author supplied keywords
Cite
CITATION STYLE
Barrantes-Freer, A., Kim, E., Bielanska, J., Giese, A., Mortensen, L. S., Schulz-Schaeffer, W. J., … Pardo, L. A. (2013). Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia. Journal of Neuropathology and Experimental Neurology, 72(4), 307–324. https://doi.org/10.1097/NEN.0b013e31828afdbd
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.